Isabella Russo

3.0k total citations
84 papers, 2.2k citations indexed

About

Isabella Russo is a scholar working on Cardiology and Cardiovascular Medicine, Physiology and Molecular Biology. According to data from OpenAlex, Isabella Russo has authored 84 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Cardiology and Cardiovascular Medicine, 26 papers in Physiology and 20 papers in Molecular Biology. Recurrent topics in Isabella Russo's work include Antiplatelet Therapy and Cardiovascular Diseases (25 papers), Nitric Oxide and Endothelin Effects (19 papers) and Pharmacology and Obesity Treatment (11 papers). Isabella Russo is often cited by papers focused on Antiplatelet Therapy and Cardiovascular Diseases (25 papers), Nitric Oxide and Endothelin Effects (19 papers) and Pharmacology and Obesity Treatment (11 papers). Isabella Russo collaborates with scholars based in Italy, Australia and United Kingdom. Isabella Russo's co-authors include Mariella Trovati, Giovanni Anfossi, Cristina Barale, Luigi Mattiello, Gabriella Doronzo, Franco Cavalot, Alessandro Morotti, Paola Massucco, Katia Bonomo and Ricardo J. S. Costa and has published in prestigious journals such as Journal of Neuroscience, PLoS ONE and Diabetes.

In The Last Decade

Isabella Russo

80 papers receiving 2.2k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Isabella Russo 690 540 515 445 338 84 2.2k
Fabiola Sinigaglia 442 0.6× 695 1.3× 699 1.4× 393 0.9× 230 0.7× 78 2.7k
Stephan Schiekofer 637 0.9× 939 1.7× 602 1.2× 254 0.6× 465 1.4× 47 2.6k
Rozenn Quarck 604 0.9× 702 1.3× 268 0.5× 424 1.0× 173 0.5× 69 2.5k
Hartmut Ruetten 838 1.2× 999 1.9× 957 1.9× 289 0.6× 296 0.9× 57 2.8k
Anca D. Dobrian 445 0.6× 806 1.5× 690 1.3× 362 0.8× 537 1.6× 59 2.7k
Daisaku Masuda 645 0.9× 684 1.3× 341 0.7× 931 2.1× 694 2.1× 96 2.5k
Héctor De León 615 0.9× 689 1.3× 598 1.2× 375 0.8× 215 0.6× 49 2.0k
Petra Ročić 751 1.1× 1.2k 2.1× 780 1.5× 297 0.7× 362 1.1× 56 2.7k
Aino Soro‐Paavonen 597 0.9× 602 1.1× 402 0.8× 450 1.0× 1.0k 3.0× 30 2.5k
Karla B Neves 574 0.8× 560 1.0× 430 0.8× 243 0.5× 301 0.9× 57 1.9k

Countries citing papers authored by Isabella Russo

Since Specialization
Citations

This map shows the geographic impact of Isabella Russo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Isabella Russo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Isabella Russo more than expected).

Fields of papers citing papers by Isabella Russo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Isabella Russo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Isabella Russo. The network helps show where Isabella Russo may publish in the future.

Co-authorship network of co-authors of Isabella Russo

This figure shows the co-authorship network connecting the top 25 collaborators of Isabella Russo. A scholar is included among the top collaborators of Isabella Russo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Isabella Russo. Isabella Russo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Radin, Massimo, Barbara Montaruli, Isabella Russo, et al.. (2025). Anti‐Phosphatidylserine/Prothrombin Antibodies Identify a Distinct Form of ITP. eJHaem. 6(5). e70154–e70154.
2.
Barale, Cristina, et al.. (2025). PCSK9 Expression in Vascular Smooth Muscle Cells: Role of Insulin Resistance and High Glucose. International Journal of Molecular Sciences. 26(3). 1003–1003. 1 indexed citations
3.
Russo, Isabella, et al.. (2023). Platelets and Cardioprotection: The Role of Nitric Oxide and Carbon Oxide. International Journal of Molecular Sciences. 24(7). 6107–6107. 21 indexed citations
4.
5.
Morotti, Alessandro, Cristina Barale, Emilia Giugliano, et al.. (2023). Aberrant Platelet Aggregation as Initial Presentation of Essential Thrombocythemia: Failure of Entero-Coated Aspirin to Reduce Platelet Hyperactivation. International Journal of Molecular Sciences. 25(1). 176–176.
6.
Cammisotto, Vittoria, Francesco Baratta, Paola Simeone, et al.. (2022). Proprotein Convertase Subtilisin Kexin Type 9 (PCSK9) Beyond Lipids: The Role in Oxidative Stress and Thrombosis. Antioxidants. 11(3). 569–569. 25 indexed citations
7.
Cammisotto, Vittoria, Francesco Baratta, Valentina Castellani, et al.. (2021). Proprotein Convertase Subtilisin Kexin Type 9 Inhibitors Reduce Platelet Activation Modulating ox-LDL Pathways. International Journal of Molecular Sciences. 22(13). 7193–7193. 36 indexed citations
8.
Costa, Ricardo J. S., et al.. (2019). Impact of exercise-induced hypohydration on gastrointestinal integrity, function, symptoms, and systemic endotoxin and inflammatory profile. Journal of Applied Physiology. 126(5). 1281–1291. 67 indexed citations
9.
Russo, Isabella, Saveria Femminò, Cristina Barale, et al.. (2018). Cardioprotective Properties of Human Platelets Are Lost in Uncontrolled Diabetes Mellitus: A Study in Isolated Rat Hearts. Frontiers in Physiology. 9. 875–875. 19 indexed citations
10.
Barale, Cristina, et al.. (2017). Glucagon-like peptide 1-related peptides increase nitric oxide effects to reduce platelet activation. Thrombosis and Haemostasis. 117(6). 1115–1128. 67 indexed citations
11.
Russo, Isabella, Cláudia Penna, Tiziana Musso, et al.. (2017). Platelets, diabetes and myocardial ischemia/reperfusion injury. Cardiovascular Diabetology. 16(1). 71–71. 64 indexed citations
12.
Russo, Isabella, Saveria Femminò, Cristina Barale, et al.. (2016). Platelets poorly controlled type 2 diabetes subjects show an impaired ability to protect against the cardiac ischaemia/reperfusion injury. Diabetologia. 59. 12–13. 1 indexed citations
13.
Trovati, Mariella, et al.. (2014). Leptin and Vascular Smooth Muscle Cells. Current Pharmaceutical Design. 20(4). 625–634. 34 indexed citations
14.
Russo, Isabella, M. Traversa, Katia Bonomo, et al.. (2009). In Central Obesity, Weight Loss Restores Platelet Sensitivity to Nitric Oxide and Prostacyclin. Obesity. 18(4). 788–797. 60 indexed citations
15.
Anfossi, Giovanni, Isabella Russo, & Mariella Trovati. (2008). Resistance to Aspirin and Thienopyridines in Diabetes Mellitus and Metabolic Syndrome. Current Vascular Pharmacology. 6(4). 313–328. 31 indexed citations
16.
17.
Doronzo, Gabriella, Isabella Russo, Luigi Mattiello, et al.. (2004). Insulin activates vascular endothelial growth factor in vascular smooth muscle cells: influence of nitric oxide and of insulin resistance. European Journal of Clinical Investigation. 34(10). 664–673. 62 indexed citations
18.
Russo, Isabella, Paola Massucco, Luigi Mattiello, et al.. (2002). Comparison between the effects of the rapid recombinant insulin analog aspart and those of human regular insulin on platelet cyclic nucleotides and aggregation. Thrombosis Research. 107(1-2). 31–37. 14 indexed citations
19.
Anfossi, Giovanni, Isabella Russo, Paola Massucco, et al.. (2002). Adenosine increases human platelet levels of 3′,5′-cGMP through nitric oxide. Thrombosis Research. 105(1). 71–78. 75 indexed citations
20.
Anfossi, Giovanni, Isabella Russo, Paola Massucco, et al.. (2001). Studies on Inhibition of Human Platelet Function by Sodium Nitroprusside. Kinetic Evaluation of the Effect on Aggregation and Cyclic Nucleotide Content. Thrombosis Research. 102(4). 319–330. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Fabiola Sinigaglia Breakdown of academic impact, for papers by Stephan Schiekofer Breakdown of academic impact, for papers by Rozenn Quarck Breakdown of academic impact, for papers by Hartmut Ruetten Breakdown of academic impact, for papers by Anca D. Dobrian Breakdown of academic impact, for papers by Daisaku Masuda Breakdown of academic impact, for papers by Héctor De León Breakdown of academic impact, for papers by Petra Ročić Breakdown of academic impact, for papers by Aino Soro‐Paavonen Breakdown of academic impact, for papers by Karla B Neves
Rankless by CCL
2026